Skip to main content

Hashtag search

#OraklOncology, a French #TechBio company using AI and real patient biology to predict how #cancer drugs will perform in clinical trials, today announced a €30 million #SeriesA 🇫🇷 🧬

Read more: https://t.co/NjWSrpilPC
4
Switchpoint Bio, a Helsinki- and Cambridge, Massachusetts-based #TechBio startup, has raised €4.75 million in pre-Seed financing. 🇫🇮 🧬 🩸💊

https://t.co/9cxoKrIeJp https://t.co/1TS3x82FFR
Post image
Switchpoint Bio, a Helsinki- and Cambridge, Massachusetts-based #TechBio startup, has raised €4.75 million in pre-Seed financing. 🇫🇮 🧬 🩸💊

https://t.co/9cxoKrIeJp
The #TechBio fundraising environment is changing. As capital becomes more selective, investors are moving beyond #AI buzzwords to focus on companies demonstrating genuine technical #depth, #impact, and #scientificvalue. 🧬🔬

In this article, #RomainClement, Founder and CEO of
You’ve reached the end 🎉